{"title":"从基因上预测肠道微生物群与多发性肌炎/皮肌炎风险之间的因果关系:孟德尔随机分析。","authors":"Yanna Niu, Yaochen Zhang, Keyi Fan, Jialin Hou, Liu Liu, Heyi Zhang, Xinlei Geng, Xiyue Ma, Shilei Lin, Meilin Guo, Xiaofeng Li, Shengxiao Zhang","doi":"10.3389/fmicb.2024.1409497","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Observational studies suggest associations between gut microbiota and polymyositis (PM) and dermatomyositis (DM), but causal relationships are unclear. We investigate the causal effects of gut microbiota on PM and DM, providing insights hoping to provide insights for future treatment and prevention.</p><p><strong>Methods: </strong>Summary statistics of gut microbiota were obtained from a multi-ethnic Genome Wide Association Studies (GWAS) meta-analysis, including 119 taxa from 18,340 Europeans. PM/DM statistics were extracted from GWAS analyses. Mendelian randomization (MR) with IVW, MR-Egger, and weighted median methods was performed. Sensitivity analyses addressed heterogeneity and pleiotropy. Of the 119 bacterial genera studied, six showed causal links.</p><p><strong>Results: </strong><i>Alloprevotella</i> (OR: 3.075, 95% CI: 1.127-8.386, <i>p</i> = 0.028), <i>Ruminococcaceae</i> UCG003 (OR: 4.219, 95% CI: 1.227-14.511, <i>p</i> = 0.022), <i>Dialister</i> (OR: 0.273, 95% CI: 0.077-0.974, <i>p</i> = 0.045) were associated with PM. <i>Anaerotruncus</i> (OR: 0.314, 95% CI: 0.112-0.882, <i>p</i> = 0.028), <i>Ruminococcaceae</i> UCG002 (OR: 2.439, 95% CI: 1.173-5.071, <i>p</i> = 0.017), <i>Sutterella</i> (OR: 3.392, 95% CI: 1.302-8.839, <i>p</i> = 0.012) were related to DM. Sensitivity analyses validated these associations.</p><p><strong>Discussion: </strong>We establish causal relationships between <i>Ruminococcaceae</i>, <i>Sutterella</i>, <i>Anaerotruncus</i> with DM, <i>Alloprevotella</i>, <i>Ruminococcaceae</i> UCG003, and <i>Dialister</i> with PM. Common microbiota, like <i>Ruminococcaceae</i>, have significant clinical implications. These findings open up greater possibilities for the gut microbiota to contribute to the development of PM/DM and for future monitoring of the gut microbiota in patients with PM/DM.</p>","PeriodicalId":12466,"journal":{"name":"Frontiers in Microbiology","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371719/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis/dermatomyositis: a Mendelian randomization analysis.\",\"authors\":\"Yanna Niu, Yaochen Zhang, Keyi Fan, Jialin Hou, Liu Liu, Heyi Zhang, Xinlei Geng, Xiyue Ma, Shilei Lin, Meilin Guo, Xiaofeng Li, Shengxiao Zhang\",\"doi\":\"10.3389/fmicb.2024.1409497\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Observational studies suggest associations between gut microbiota and polymyositis (PM) and dermatomyositis (DM), but causal relationships are unclear. We investigate the causal effects of gut microbiota on PM and DM, providing insights hoping to provide insights for future treatment and prevention.</p><p><strong>Methods: </strong>Summary statistics of gut microbiota were obtained from a multi-ethnic Genome Wide Association Studies (GWAS) meta-analysis, including 119 taxa from 18,340 Europeans. PM/DM statistics were extracted from GWAS analyses. Mendelian randomization (MR) with IVW, MR-Egger, and weighted median methods was performed. Sensitivity analyses addressed heterogeneity and pleiotropy. Of the 119 bacterial genera studied, six showed causal links.</p><p><strong>Results: </strong><i>Alloprevotella</i> (OR: 3.075, 95% CI: 1.127-8.386, <i>p</i> = 0.028), <i>Ruminococcaceae</i> UCG003 (OR: 4.219, 95% CI: 1.227-14.511, <i>p</i> = 0.022), <i>Dialister</i> (OR: 0.273, 95% CI: 0.077-0.974, <i>p</i> = 0.045) were associated with PM. <i>Anaerotruncus</i> (OR: 0.314, 95% CI: 0.112-0.882, <i>p</i> = 0.028), <i>Ruminococcaceae</i> UCG002 (OR: 2.439, 95% CI: 1.173-5.071, <i>p</i> = 0.017), <i>Sutterella</i> (OR: 3.392, 95% CI: 1.302-8.839, <i>p</i> = 0.012) were related to DM. Sensitivity analyses validated these associations.</p><p><strong>Discussion: </strong>We establish causal relationships between <i>Ruminococcaceae</i>, <i>Sutterella</i>, <i>Anaerotruncus</i> with DM, <i>Alloprevotella</i>, <i>Ruminococcaceae</i> UCG003, and <i>Dialister</i> with PM. Common microbiota, like <i>Ruminococcaceae</i>, have significant clinical implications. These findings open up greater possibilities for the gut microbiota to contribute to the development of PM/DM and for future monitoring of the gut microbiota in patients with PM/DM.</p>\",\"PeriodicalId\":12466,\"journal\":{\"name\":\"Frontiers in Microbiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371719/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Microbiology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.3389/fmicb.2024.1409497\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmicb.2024.1409497","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis/dermatomyositis: a Mendelian randomization analysis.
Introduction: Observational studies suggest associations between gut microbiota and polymyositis (PM) and dermatomyositis (DM), but causal relationships are unclear. We investigate the causal effects of gut microbiota on PM and DM, providing insights hoping to provide insights for future treatment and prevention.
Methods: Summary statistics of gut microbiota were obtained from a multi-ethnic Genome Wide Association Studies (GWAS) meta-analysis, including 119 taxa from 18,340 Europeans. PM/DM statistics were extracted from GWAS analyses. Mendelian randomization (MR) with IVW, MR-Egger, and weighted median methods was performed. Sensitivity analyses addressed heterogeneity and pleiotropy. Of the 119 bacterial genera studied, six showed causal links.
Results: Alloprevotella (OR: 3.075, 95% CI: 1.127-8.386, p = 0.028), Ruminococcaceae UCG003 (OR: 4.219, 95% CI: 1.227-14.511, p = 0.022), Dialister (OR: 0.273, 95% CI: 0.077-0.974, p = 0.045) were associated with PM. Anaerotruncus (OR: 0.314, 95% CI: 0.112-0.882, p = 0.028), Ruminococcaceae UCG002 (OR: 2.439, 95% CI: 1.173-5.071, p = 0.017), Sutterella (OR: 3.392, 95% CI: 1.302-8.839, p = 0.012) were related to DM. Sensitivity analyses validated these associations.
Discussion: We establish causal relationships between Ruminococcaceae, Sutterella, Anaerotruncus with DM, Alloprevotella, Ruminococcaceae UCG003, and Dialister with PM. Common microbiota, like Ruminococcaceae, have significant clinical implications. These findings open up greater possibilities for the gut microbiota to contribute to the development of PM/DM and for future monitoring of the gut microbiota in patients with PM/DM.
期刊介绍:
Frontiers in Microbiology is a leading journal in its field, publishing rigorously peer-reviewed research across the entire spectrum of microbiology. Field Chief Editor Martin G. Klotz at Washington State University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.